Perihilar Markings on Chest X-Ray: Clinical Significance and Management
What Perihilar Markings Signify
Perihilar markings represent the radiographic appearance of central pulmonary vessels, airways, and surrounding interstitial structures; when prominent or abnormal, they most commonly indicate pulmonary vascular congestion, pulmonary hypertension, lymphadenopathy, or interstitial lung disease. 1, 2
Primary Pathologic Considerations
Pulmonary hypertension manifests as enlarged main and hilar pulmonary arterial shadows with concomitant attenuation of peripheral vascular markings ("pruning"), a pattern present in most patients with idiopathic pulmonary arterial hypertension. 1
A right interlobar artery measurement >15 mm in women or >16 mm in men at the hilum is suggestive of pulmonary hypertension, with 93% sensitivity and 88% specificity. 2, 3
Hilar and mediastinal lymphadenopathy from lung cancer, sarcoidosis, or tuberculosis can present as prominent perihilar markings, though chest radiography has limited sensitivity (missing up to 72% of lesions) for detecting mediastinal lymph node involvement. 4, 3
Interstitial edema or hemorrhage along bronchovascular sheaths can produce enlarged, ill-defined perihilar markings—particularly important to recognize in acute aortic rupture where this represents hemorrhage rather than edema. 5
Chronic bronchiectasis (as in cystic fibrosis) demonstrates bronchial thickening and dilatation, peribronchial cuffing, and increased interstitial markings radiating from the hila. 6
Evaluation Algorithm
Initial Assessment
Obtain PA and lateral chest radiographs as the first-line imaging modality, recognizing that portable AP films have significantly lower sensitivity for detecting pathology. 1, 2, 3
Assess technical quality including proper penetration, rotation, and inspiration before interpreting mediastinal and hilar contours, as rotation can mimic or obscure true pathology. 3
Systematically evaluate the trachea, main bronchi, mediastinal width, aortopulmonary window, and both hilar regions for masses, lymphadenopathy, or vascular enlargement. 3
Risk Stratification
High-risk features requiring aggressive workup include: smoking history >20 pack-years, older age, upper lobe location of associated nodules, irregular or spiculated margins, and progressive symptoms. 4
Measure pulmonary artery dimensions: main pulmonary artery >35 mm from midline to left lateral border or right descending pulmonary artery >15 mm (women) or >16 mm (men) strongly suggests pulmonary hypertension. 3, 7
Advanced Imaging Indications
Proceed immediately to contrast-enhanced chest CT when perihilar abnormalities are identified on chest radiography, as CT is the gold standard for evaluating hilar fullness and provides superior spatial localization. 4, 3
Do not rely on chest radiography alone—up to 72% of mediastinal lesions may be missed, and sensitivity for detecting mild pulmonary hypertension or early lymphadenopathy is inadequate. 2, 4, 3
Transthoracic Doppler echocardiography should always be performed when pulmonary hypertension is suspected, with sensitivity of 79-100% and specificity of 68-98% for detecting moderate pulmonary hypertension. 2, 7
Management Approach
When Pulmonary Hypertension is Suspected
Order chest CT with IV contrast to evaluate for chronic thromboembolic pulmonary hypertension (CTEPH), which shows cardiomegaly (86%), right ventricular enlargement (68%), mosaic oligemia (68%), and right descending pulmonary arterial enlargement (55%). 1
Obtain ventilation-perfusion (V/Q) scanning, which is more sensitive than CT for detecting CTEPH—a potentially curable condition that must not be missed. 7
Perform right heart catheterization for definitive diagnosis when mean pulmonary artery pressure >20 mmHg is suspected based on non-invasive testing. 7
When Lymphadenopathy or Malignancy is Suspected
Obtain FDG-PET whole body imaging in patients with smoking history and hilar adenopathy to assess metabolic activity, though recognize that sarcoidosis and tuberculosis can also show high PET-CT uptake. 8, 4
Pursue tissue diagnosis via endobronchial ultrasound-guided needle aspiration (EBUS-NA) for accessible hilar/mediastinal nodes when malignancy or lymphoma are suspected—this is the preferred initial invasive approach. 4
Never assume malignancy without histological confirmation, as benign conditions like sarcoidosis (which can present with miliary pattern and mediastinal widening) and tuberculosis can mimic cancer. 4, 9
Critical Pitfalls to Avoid
Do not order CT without and with contrast (dual-phase) for hilar mass evaluation—there is no supporting literature for this approach. 4
Do not dismiss normal chest radiography when clinical suspicion remains high; approximately 40% of patients with "normal" chest radiographs may have significant pathology detected on CT. 3
Do not overlook pulmonary veno-occlusive disease (PVOD) when pulmonary artery dilation is disproportionate to hemodynamic severity and DLCO is severely reduced (<45% predicted), as pulmonary vasodilator therapy can precipitate life-threatening pulmonary edema. 7
Recognize that absence of peripheral vascular pruning does not exclude pulmonary hypertension—this finding lacks sufficient sensitivity to serve as a screening tool. 1
In acute aortic rupture, enlarged bronchovascular markings represent interstitial hemorrhage along perivascular sheaths, not pulmonary edema—this distinction has critical therapeutic implications. 5